
Glomatinib 400mg Tablet
Marketer
Globela Pharma Pvt Ltd
Salt Composition
Imatinib mesylate (400mg)
Overview Glomatinib 400mg Tablet
Ponatinib 400mg tablets are indicated for various cancers. Primarily, it's used to manage hematological malignancies such as chronic myeloid leukemia and acute lymphoblastic leukemia, along with gastrointestinal stromal tumors. Its mechanism involves targeting specific proteins crucial for cancer cell proliferation and metastasis. This medication also treats dermatofibrosarcoma protuberans (a skin tumor) and aggressive systemic mastocytosis (a bone marrow disorder). Administer this drug with food, consistently at the same time daily for optimal efficacy. Continue treatment as directed by your physician; duration is individualized based on response and clinical need. Incorrect dosage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; do not discontinue without medical consultation. Common side effects comprise edema, nausea, vomiting, myalgia, musculoskeletal pain, diarrhea, skin rash, asthenia, and abdominal discomfort. Report any sudden, unexplained weight gain. Your doctor may order regular blood counts and liver function tests. Avoid activities requiring alertness if dizziness or blurred vision occur. Inform your healthcare provider of all concurrent medications, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment.
Primary Ingredients of Glomatinib 400mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Glomatinib 400mg Tablet
Oncological Management
Major Benefits of Glomatinib 400mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 400mg Glomatinib tablet should be administered with a meal.
Common Side effects of Glomatinib 400mg Tablet:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Glomatinib 400mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 400mg Glomatinib tablet should be administered with a meal.
How Glomatinib 400mg Tablet works:
Glomatinib 400mg tablets are an anticancer drug targeting the bcr-abl tyrosine kinase enzyme. This enzyme drives the uncontrolled growth of cancerous cells. By inhibiting bcr-abl kinase activity, glomatinib suppresses the proliferation of bcr-abl-positive cancer cells and triggers their programmed death (apoptosis), thus hindering or slowing cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Glomatinib 400mg tablets lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of the 400mg Glomatinib tablet during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of 400mg Glomatinib tablets while breastfeeding is likely unsafe. Preliminary human evidence indicates potential drug transfer to breast milk, posing a risk to the infant. Nursing mothers should discontinue breastfeeding during Glomatinib treatment and for a fortnight following its cessation.
DrivingUNSAFE
Taking a 400mg Glomatinib tablet may impair driving ability due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should use Glomatinib 400mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Glomatinib 400mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Glomatinib 400mg Tablet :
Omit any missed Glomatinib 400mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glomatinib 400mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzanilide derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | TKIs (tyrosine kinase inhibitors) |
